Perplexity AI Predicts Whether Moderna Stock Can Make Investors Rich in 2026
A single trial readout simply doubled an organization’s market worth in one session. Perplexity AI predicts the rerating continues, and the worth prediction locations Moderna at $180 to $240 by the top of 2026 with a $210 bullish base case. The catalyst is Intismeran, the customized mRNA most cancers vaccine. Perplexity calls it the dominant…